» Articles » PMID: 8197529

Diabetic Foot Infections. Pathophysiology and Treatment

Overview
Specialty General Surgery
Date 1994 Jun 1
PMID 8197529
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Foot infections are among the most common reasons for hospital admission of the diabetic patient. A diabetic foot infection represents a failure by the patient and his management team to understand and correct the multifactorial conditions that predisposed the patient to the infection. Efforts directed toward prevention of the foot infection are much more likely to meet with success than is therapy of the established foot infection. This preventive approach is likely to lead to a reduction in the incidence of major amputations and thereby improve life expectancy. Understanding the pathophysiology associated with the diabetic foot is essential to the care of the diabetic patient. If a breach in skin integrity occurs, prompt assessment of vascular, neural, soft tissue, and wound status enhances the possibility of a successful clinical outcome. The complexity of the management of a diabetic requires the knowledge and skill of a multidisciplinary team, which usually includes an internist, podiatrist, rehabilitation specialist, prosthetist, dietitian, and social worker in addition to a surgeon interested in caring for the complications of diabetic feet. The goals of this multispecialty group are to optimize local wound care, provide correct foot wear, improve glucose control, educate the patient concerning diet and life style changes, and identify the presence of peripheral neuropathies and reconstructable arterial lesions. This combined medical team approach has been documented to substantially reduce the incidence of major and minor amputations in the diabetic.

Citing Articles

Understanding the multifaceted etiopathogenesis of foot complications in individuals with diabetes.

Matijevic T, Talapko J, Mestrovic T, Matijevic M, Eric S, Eric I World J Clin Cases. 2023; 11(8):1669-1683.

PMID: 36970006 PMC: 10037285. DOI: 10.12998/wjcc.v11.i8.1669.


An economic evaluation examining the cost-effectiveness of continuous diffusion of oxygen therapy for individuals with diabetic foot ulcers.

Chan B, Campbell K Int Wound J. 2020; 17(6):1791-1808.

PMID: 33189100 PMC: 7754389. DOI: 10.1111/iwj.13468.


Is high level of hemoglobin A1C an indicator for extended period of antibiotherapy in diabetic foot ulcers?.

Dogan M, Onar L, Aydin B, Gumustas S North Clin Istanb. 2019; 6(1):21-27.

PMID: 31180382 PMC: 6526988. DOI: 10.14744/nci.2018.25582.


Redefined clinical spectra of diabetic foot syndrome.

Shatnawi N, Al-Zoubi N, Hawamdeh H, Khader Y, Omari A, Khammash M Vasc Health Risk Manag. 2018; 14:291-298.

PMID: 30425505 PMC: 6201996. DOI: 10.2147/VHRM.S169502.


MIDFOOT CHARCOT ARTHROPATHY IN DIABETIC PATIENTS: COMPLICATION OF AN EPIDEMIC DISEASE.

Ferreira R, Goncalez D, Fonseca Filho J, Costa M, Santin R Rev Bras Ortop. 2016; 47(5):616-25.

PMID: 27047875 PMC: 4799459. DOI: 10.1016/S2255-4971(15)30013-6.